PSG
ABBV icon

Planning Solutions Group’s AbbVie ABBV Stock Holding History

Planning Solutions Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$260K Sell
3,571
-250
-7% -$19.6K 0.13% 113
2019
Q1 		$308K Sell
3,821
-1,221
-24% -$99.9K 0.17% 99
2018
Q4 		$465K Buy
+5,042
New +$443K 0.28% 70

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Planning Solutions Group's ABBV Position: Q2 2019 in Review

Planning Solutions Group reduced its AbbVie (ABBV) stake by 6.5% in Q2 2019, selling an estimated $19.6K and leaving 3,571 shares worth $260K. The position accounts for 0.13% of the portfolio, ranked #113.

Planning Solutions Group first reported a position in ABBV in Q4 2018 and has held it in 3 quarters since. The position peaked at $465K in Q4 2018. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

  • Planning Solutions Group held 3,571 shares of AbbVie worth $260K as of Q2 2019.
  • Planning Solutions Group sold 250 AbbVie shares in Q2 2019, an estimated $19.6K.
  • AbbVie made up 0.13% of Planning Solutions Group's portfolio in Q2 2019, its #113 holding.
  • Planning Solutions Group first reported a position in AbbVie in Q4 2018 and has held it in 3 quarters since.
  • Planning Solutions Group's AbbVie position peaked at $465K in Q4 2018.
  • 2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Planning Solutions Group's 13F filing for Q2 2019, filed 15 Aug 2019.